Heterogeneity in the presentation of clinical type 1 diabetes defined by the level of risk conferred by human leukocyte antigen class II genotypes

Corresponding Author

Mikael Knip

Pediatric Research Center, Children's Hospital, University of Helsinki and Helsinki University Hospital, Helsinki, Finland

Research Program for Clinical and Molecular Metabolism, Faculty of Medicine, University of Helsinki, Helsinki, Finland

Tampere Center for Child Health Research, Tampere University Hospital, Tampere, Finland

Correspondence

Mikael Knip, University of Helsinki, Biomedicum 1, Haartmaninkatu 8, 00290 Helsinki, Finland.

View original article

0 0 0 0 0 0 0

留言 (0)